德聯集團(002666.SZ)業績快報:2021年度淨利升10.61%至2.57億元
格隆匯3月17日丨德聯集團(002666.SZ)披露2021年度業績快報,2021年,公司繼續開拓國內汽車廠市場,汽車精細化學品業務持續增加,公司業績保持穩步增長。報吿期內,公司實現營業收入51.96億元,同比增長16.29%;營業利潤3.11億元,同比增長14.53%;利潤總額3.12億元,同比增長9.50%;歸屬上市公司股東淨利潤2.57億元,同比增長10.61%。
報吿期末,公司財務狀況良好,總資產為45.55億元,較年初增長7.29%,歸屬於上市公司股東的所有者權益為33.61億元,較年初增長5.46%,歸屬於上市公司股東的每股淨資產為4.45元,較年初增長5.45%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.